Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Axsome Therapeutics Q1 EPS $(1.03) Misses $(1.00) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(1.00) by 3 percent. This is a 32.05 percent decrease over losses of $(0.78) per share from
byBenzinga Newsdesk
May 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(1.00) by 3 percent. This is a 32.05 percent decrease over losses of $(0.78) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What To Expect On Killer Mike’s New Show Tumbleweeds, And Has He Smoked With Bernie Sanders Yet?

By Andrew Ward
April 6, 9:00 AM
Weedmaps WM Technology Inc (NASDAQ: MAPS) and hip hop star Killer Mike announced the launch of their new media project Tumbleweeds. The show will follow Killer Mike, real name Michael Render, exploring what show creators call "a new era of cannabis in America."

MAPS